← Eichor
Study identifier: NCT06690632 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

WAter Preparation in Crohn's Disease's Imagery

Condition: Crohn Disease (CD)  ·  Sponsor: University Hospital, Toulouse

PhaseNA
Planned participants194
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to compare distension quality and patient experience of water and polyethylene glycol preparation as oral contrast media in Magnetic Resonance Enterography (MRE) in patients with Crohn's disease. Thus, the main question it aims to answer is: Is water sufficient to interpret MRE from patients with Crohn's disease? Researchers will compare the standard protocol (polyethylene glycol) with water as bowel distension agent to see if it is possible to obtain a satisfying global distension of small bowel. Participants will undergo the same procedures as standard care adding questionnaires and replacing water as the bowel distension agent for the MRE for patient randomized into the experimental group.

This description comes directly from the study's public registry record.

Talk to the study team

Guillaume Dr LE COSQUER, MD  ·  +33 (0)5 61 32 20 45  ·  lecosquer.g@chu-toulouse.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU ToulouseToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06690632